Cargando…
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
Colorectal cancer is one of the main causes of cancer death worldwide, and novel biomarkers are urgently needed for its early diagnosis and treatment. The utilization of metabolomics to identify and quantify metabolites in body fluids may allow the detection of changes in their concentrations that c...
Autores principales: | Martín-Blázquez, Ariadna, Díaz, Caridad, González-Flores, Encarnación, Franco-Rivas, Daniel, Jiménez-Luna, Cristina, Melguizo, Consolación, Prados, José, Genilloud, Olga, Vicente, Francisca, Caba, Octavio, Pérez del Palacio, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934557/ https://www.ncbi.nlm.nih.gov/pubmed/31882610 http://dx.doi.org/10.1038/s41598-019-55952-8 |
Ejemplares similares
-
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020) -
Untargeted Metabolomics for the Diagnosis of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis
por: Díaz, Caridad, et al.
Publicado: (2021) -
Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics
por: Jimenez-Luna, Cristina, et al.
Publicado: (2020) -
LC-HRMS Metabolomics for Untargeted Diagnostic Screening in Clinical Laboratories: A Feasibility Study
por: Rochat, Bertrand, et al.
Publicado: (2018) -
LC-HRMS data as a result of untargeted metabolomic profiling of human cerebrospinal fluid
por: Mehl, Florence, et al.
Publicado: (2018)